A citation-based method for searching scientific literature

Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni, Hiroshi Hiai, Wataru Mizunoya, Tohru Fushiki, Jens Juul Holst, Mitsuhiro Makino, Akira Tashita, Yukari Kobara, Yoshiharu Tsubamoto, Takayoshi Jinnouchi, Takahito Jomori, Yutaka Seino. Nat Med 2002
Times Cited: 610



K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe, K Tsuda, H Hashimoto, T Yamashita, T Jomori, F Tashiro, J Miyazaki, Y Seino. Proc Natl Acad Sci U S A 1999
Times Cited: 349




List of shared articles



Times cited


GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Geke Aline Boer, Stacey N Keenan, Paula M Miotto, Jens Juul Holst, Matthew J Watt. Am J Physiol Endocrinol Metab 2021
1

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
Shu-Chen Lu, Michelle Chen, Larissa Atangan, Elizabeth A Killion, Renee Komorowski, Yuan Cheng, Chawita Netirojjanakul, James R Falsey, Marina Stolina, Denise Dwyer,[...]. Cell Rep Med 2021
0

Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?
Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, Yuichiro Yamada, Murielle M Véniant, David J Lloyd. Endocr Rev 2020
19


Pharmacological antagonism of the incretin system protects against diet-induced obesity.
Berit Svendsen, Megan E Capozzi, Jingjing Nui, Sarah A Hannou, Brian Finan, Jacqueline Naylor, Peter Ravn, David A D'Alessio, Jonathan E Campbell. Mol Metab 2020
14


Incretins in obesity and diabetes.
Chee W Chia, Josephine M Egan. Ann N Y Acad Sci 2020
19

Islet adaptation in GIP receptor knockout mice.
Bo Ahrén, Yuchiro Yamada, Yutaka Seino. Peptides 2020
1

Recent advances of GIP and future horizons.
Jens Juul Holst, Mette Marie Rosenkilde. Peptides 2020
6

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis.
Gemma Pujadas, Elodie M Varin, Laurie L Baggio, Erin E Mulvihill, K W Annie Bang, Jacqueline A Koehler, Dianne Matthews, Daniel J Drucker. Mol Metab 2020
4

Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.
Yukiko Fu, Kentaro Kaneko, Hsiao-Yun Lin, Qianxing Mo, Yong Xu, Takayoshi Suganami, Peter Ravn, Makoto Fukuda. Endocrinology 2020
6

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Piotr A Mroz, Brian Finan, Vasily Gelfanov, Bin Yang, Matthias H Tschöp, Richard D DiMarchi, Diego Perez-Tilve. Mol Metab 2019
60

Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
Yuki Murata, Norio Harada, Shunsuke Yamane, Kanako Iwasaki, Eri Ikeguchi, Yoshinori Kanemaru, Takanari Harada, Akiko Sankoda, Satoko Shimazu-Kuwahara, Erina Joo,[...]. Am J Physiol Endocrinol Metab 2019
3

Inhibition of GIP signaling extends lifespan without caloric restriction.
Manabu Hoizumi, Takehiro Sato, Tatsunori Shimizu, Shunsuke Kato, Katsushi Tsukiyama, Takuma Narita, Hiroki Fujita, Tsukasa Morii, Mariko Harada Sassa, Yutaka Seino,[...]. Biochem Biophys Res Commun 2019
4